Germany

Tue
04
Jun

Germany: Explore the world of medical cannabis delivery systems, patient experience and more

Dr Franjo Grotenhermen, founder and Chairman of the ACM and IACM, provides a deeper insight into medical cannabis delivery systems in Germany, along with patient experience and more.

Tue
21
May
Tue
07
May

Long-awaited German tenders handed to specialist trio

White smoke emanating from Germany’s medical agency signals the wait is over to find out which firms have been awarded medicinal cannabis tenders for Europe’s top market.

Two Canadian firms, Aphria, and Aurora Cannabis and Germany’s Demecan have won out, it has emerged.

The three companies will split a four-year tender to grow 10,400kg between them. Aphria won five of the 13 lots, with Aurora Cannabis and Demecan handed five and three lots respectively.

Fri
03
May

Canopy Growth acquires German Synthetic Cannabis Company C3 for $250 Million

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is acquiring the German-based, Bionorica SE-founded C3 Cannabinoid Compound Company in an all-cash deal valued at €225.9 million (CDN $342.9 million) or roughly $250 million. The move is intended to expand Canopy Growth’s reach in Europe.

Wed
01
May

Germany prepares for domestic cannabis cultivation

Germany is awarding contracts to domestic cannabis growers in an attempt to develop its medical industry and become less reliant on imports.

BfArM – the Federal Institute for Drugs and Medical Devices of Germany – announced last Wednesday that it would purchase a total of 7,200 kilograms of cannabis over the next four years from German cultivation subsidiaries of Canadian companies Aurora Cannabis and Aphria.

Fri
26
Apr

German company to begin importing medical cannabis from Latin America

A German cannabis wholesaler and distributor has announced that they have become the first European company to import medical cannabis products from Latin America for preliminary testing.

On Wednesday, Frankfurt-based Cansativa revealed that they would be importing a variety of cannabis flower and extract products from Uruguay and Colombia to be tested by independent German laboratories for heavy metals, pesticides, and other contaminants.

In 2013, Uruguay became the first country in the world to completely legalize marijuana, though sales did not begin until July of 2017.

Thu
18
Apr

Germany to launch cannabis farming as Canada's Aurora, Aphria win tenders​

Germany has awarded contracts to supply domestically-grown cannabis to two Canadian companies, as it seeks to develop its own medicinal marijuana industry and reduce reliance on imports.

Drugs regulator BfArM said on Wednesday it would purchase 4,000 kg and 3,200 kg of cannabis over four years from German production subsidiaries of Canada's Aurora Cannabis and Aphria, respectively.

Another tender over a four-year harvest of 3200 kg has been delayed because an unidentified bidder who lost out is challenging the procedure with a regulator.

Wed
17
Apr

Euro stakeholders take a stand in Germany over ‘novel foods’

Hemp food stakeholders in Europe have taken a stand over hemp extracts in Germany after that country’s Federal Office of Consumer Protection and Food Safety (BVL) last month declared CBD may not be sold in food.

Calling the declaration, published March 20 on BVL’s web site, “strange and incomprehensible,” the European Industrial Hemp Association (EIHA), rebutted the ruling in a sharp and detailed 10-page letter April 11.

“Consumer and employees of (EIHA) members… are confused. Some (EIHA) members… that legally produce and/or sell CBD-containing cannabis products for consumption are quasi-publicly classified in a sort of ‘illegal industry’ and discriminated against,” the letter said.

Fri
05
Apr

Aurora Cannabis awarded maximum number of lots in German cannabis production tender

Read full article here.

 Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has been selected by the German Bundesinstitut für Arzneimittel und Medizinprodukte BfArM (Federal Institute for Drugs and Medical Devices) as one of three winners in the public tender to cultivate and distribute medical cannabis in Germany. The contract will be formalized at the earliest on April 17, 2019, pending the outcome of an appeal procedure on which a ruling is anticipated by April 10, 2019.

Mon
01
Apr

Will Germany become the world's largest market for medicinal cannabis?

As Europe's biggest cannabis investor conference kicked off in Berlin on Sunday, the most important topic was the future cultivation of the plant in Germany, according to German Hemp Association (DHV) Chief Executive Georg Wurth. He finds it rather pathetic that there still is no cannabis cultivation in Europe's biggest economy.

Pages

Subscribe to RSS - Germany